Education
About Us
Working with TipRanks
Follow Us
Christopher J Calamari Insider Profile
4 Followers
Christopher J Calamari, Senior Vice-President at Abbott Laboratories, holds 59.03K shares in Abbott Laboratories (Ticker: ABT). Most recently, Christopher J Calamari ― shares of Abbott Laboratories on ― for an estimated value of ―.
Christopher J Calamari has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher J Calamari's holdings
Insider Roles
Senior Vice-President
Roles that Christopher J Calamari holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christopher J Calamari
Christopher J Calamari's Trading History
List of latest transactions for each holding click on a transaction to see Christopher J Calamari's performance on stock
You May Also Like
Christopher J Calamari insider profile FAQ
What is the percentage of profitable transactions made by Christopher J Calamari?
The percentage of profitable transactions made by Christopher J Calamari is ―.
What is the average return per transaction made by Christopher J Calamari?
The average return per transaction made by Christopher J Calamari is ―.
What stocks does Christopher J Calamari hold?
Christopher J Calamari holds: ABT stocks.
What was Christopher J Calamari’s latest transaction?
Christopher J Calamari latest transaction was an Uninformative Buy of ―.
What was Christopher J Calamari's most profitable transaction?
Christopher J Calamari’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christopher J Calamari's role in Abbott Laboratories?
Christopher J Calamari's role in Abbott Laboratories is Senior Vice-President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.